Materials and Methods Reagents
Type III, Sigma) just before use, if urea is present. Omit the urease in those cases where tenate solutions or eluates from the column are being assayed.
Canaline:
Prepare this from canaline dipicrate (Sigma) as described before for the synthesis of ureidohomoserine (1) . Combine and lyophilize the canaline solutions from the ion-exchange chromatographic step. Redissolve the residue in a minimum of hot water (0.5 ml) and add 4 ml of cold ethanol, with mixing. Refrigerate the solution at 4 #{176}C overnight. Filter the white crystalline precipitate, wash it with cold ethanol, and recrystallize it from water-ethanol, using the same volumes as for the initial crystallization.
Dry the material over sodium hydroxide, under reduced pressure. The melting point should be 202-205 #{176}C (with decomposition).
Ureidohomoserine: Prepare DL-O-ureidohomoserine as described elsewhere (1) .
Perchionic acid (1 mol Biuret reagent: Dilute 2 g of CuSO4.5H2O to 100 ml with water. On the day of the test add NaOH solution (25 g/100 ml) to this copper sulfate solution in a volume ratio of 5/1 (e.g., 25 ml of NaOH and 5 ml of copper sulfate solution).
Ornithine Again centrifuge the solution to obtain a supernate and residue.
The volumes obtained and the amount of ammonium sulfate added in each case are shown in Table 1 .
In each case, dissolve the residue in 5 ml of the extraction buffer. Dialyze aliquots of the two supernatant fractions and the solutions of the residues at 4 #{176}C against the 20 mmol/liter triethanolamine buffer in continuous flow for 24 h, using a 600 ml/h flow rate of buffer.
The protein content of each tenate solution (dialysand) was assayed with biuret solution, and its enzymatic activity determined, with canaline and ornithine as substrates.
The residue from the 70%-saturated ammonium sulfate fraction, which had been dialyzed, was fractionated on a column containing Sephadex.
Fractionation by chromatography Sephadex:
A 75 X 2.5 cm column was loaded with Sephadex G-150. Three milliliters of the dialyzed liver extract precipitated by 70%-saturated ammonium sulfate, containing 138 mg of protein, was applied to the column. The developing buffer was the 20 mmol/liter triethanolamine buffer. Fractions of 2.6 ml were collected for a total of The eluate from the column was monitored continuously at 280 nm for its protein content. The protein content in the major fractions was determined by the biuret reaction: 1 ml of eluate plus 1 ml of biuret reagent was read vs. a blank of 1 ml of buffer plus 1 ml of biuret reagent, and a set of standards prepared with bovine serum albumin. The enzymatic activity of each fraction was assayed as described below.
Assay Procedures

Measurement
of canaline carbamoyltransferase activity (6) (7) (8) (9) (10) (11) (12) : The final volume in each reaction mixture was 300 gil: 100 ILlof ornithine or canaline solution, 100 ILlof carbamoyl phosphate solution, 50 il of human liver extract, and 50 ILl of the 0.2 mol/liter triethanolamine buffer. When inhibitors were used to determine inhibitor constants (K1) they were dissolved in the 50 ILlof buffer. Blanks, containing all components except enzyme, were also incubated with the reaction mixtures. Incubation was for 5 mm at 37 #{176}C except where otherwise indicated. For determination of Michaelis constants (Km), the concentration of ornithine, canaline, or carbamoyl phosphate solutions was varied. The carbamoyl phosphate solution was kept in an ice bath and was added immediately before the reaction was started by adding the human liver extract. The reaction was stopped by adding 250 ILlof perchloric acid (1 mol/liter) and immersing the reaction tube in ice. The reaction mixtures were centrifuged and the supernate was removed. The reaction rate was followed by measuring the rate at which citruffine or ureidohomoserine were produced.
Citrulline was assayed by using the above-described citrulline reagent (9) . Aliquots (50-250 Ml) of the centrifuged, perchloric acid-treated reaction mixtures were used. One milliliter of the citrulline reagent was added, followed by 250 Miof the 10 g/liter diacetyl monoxime solution. The reaction mixture was mixed, heated at 100 #{176}C for 20 mm, cooled in an ice bath in the dark for 10 mm, and the absorbance measured at 460 nm.
Ureidohomoserine was determined by using the ureidohomoserine reagent (6) . Aliquots (250-500 Ml) of the centrifuged, perchloric acid-treated reaction mixtures were mixed with 500 Mlof the reagent, and 250 ILl of concentrated sulfuric acid was added. The reaction mixtures were mixed, heated at 100 #{176}C for 3 min, cooled in an ice bath for 10 mm, and the absorbance was measured at 542 nm within 45 mm.
Resufts Figure 2 shows the pH-activity curves for human liver extract and a highly purified ornithine carbamoyltransferase from Streptococcus faecalis when orriithine or canaline is used as substrate.
With ornithine as a substrate (Figure 2A) , a broad peak with a maximum at pH 7.6 is shown for the human liver extract. For the bacterial enzyme the optimum pH is at 8.5. With canaline as the substrate (Figure 2B ), the optimum pH for the human liver extract is at 7.9 and for the bacterial enzyme at 8.4.
In subsequent experiments comparing the ornithine and canaline carbamoyltransferase activities of human liver extract, we chose a pH of 7.8 as a compromise because it was desirable to use the same pH when comparing activities. In the case of ornithine carbamoyltransferase there is only a 3% difference in activity from the optimum pH of 7.6. Table 2 lists the Michaelis-Menten constants for the purified enzyme preparation from human liver. Where ornithine and canaline were varied, the carbamoyl phosphate concentration was held constant at 1.0 and 1.5 mmol/liter.
Results for a typical experiment are shown for canaline in Figure 3 . When ornithine was held constant and carbamoyl phosphate was varied, the ornithine concentration was held at 0.5 and 0.25 mmol/ liter. Figure 4 shows a typical curve for canaline where canaline was held constant at 10 mmol/liter and carbamoyl phosphate was varied. Figure 5 shows the relative reaction rates for ornithine carbamoyltransferase and canaline carbamoyltransferase, for the purified human liver enzyme preparation from the Sephadex column. The protein concentration was 192 mg/liter, canaline and ornithine each were 5 mmol/liter, and carbamoyl phosphate was 0.5 mmol/ liter in the experiment illustrated. Table 3 summarizes the data for fractions of the initial liver extract precipitated by various concentrations of ammonium sulfate. Most of the activity was obtained with the fraction precipitating between 60 and 70% saturation with ammonium sulfate. About half of the ornithine transferase and 24% of the canaline transferase activity was lost during the fractionation, but the specific activity was increased by 41 and 126%, respectively, in the process.
The fractionation of the 60-70% ammonium sulfate fraction on the Sephadex column is shown in Figure 6 . Two major peaks were obtained when protein was measured; most of the protein in the fraction is inert, as demonstrated by the activity curves. Canaline and ornithine carbamoyltransferases were not clearly resolved. Table 4 lists the effect of certain substances on the initial reaction velocities of the activity of canaline carbamoyltransferase.
It will be noted that ornithine does not greatly inhibit this activity (only by 13%). However, the product of the reaction, ureidohomoserme, is a strong inhibitor (72%).
Parallel experiments performed with ornithine as the substrate indicated that citrulline inhibits ornithine carbamoyltransferase activity by 87%, while canaline inhibits the ornithine system by only 15%. Thus in both cases the product of the reaction has a greater effect than does the competing substrate. Note that citrulline will inhibit the canaline system by 25%. With the ornithine system, ureidohomoserine produced 46% inhibition. Thus both citrulline and ureidohomoserine can compete with either substrate for the active site. Figure 7A shows graphically the strong competitive inhibiting action of ureidohomoserine on the canaline carbamoyltransferase system. To obtain inhibition of the ornithine carbamoyltransferase system by canaline ( Figure 7B) , a more than 10-fold higher concentration is required. The K for ureidohomoserine is 0.65, as compared to 11.2 for canaline.
Discussion
As can be seen from Figure 1 and the references, all the steps in the guanidino cycle have now been documented as taking place with human liver enzyme preparations (1) (2) (3) (4) (5) . Figure 1 illustrates the alternative production of guanidinoacetate or guanidinosuccinate. It also indicates that canaline is the key substance that cycles, carrying an aspartate molecule, stripping it of ammonia and generating fumarate. It is apparent that for this cycle to continue, any canaline lost by attrition needs to be replaced. Its position in this cycle is analogous to that of oxaloacetate in the urea cycle.
We postulate that the canaline originates from aspartate. This suggestion is based on the observation that there is no transamidination to aspartate, and that radioactive aspartate, administered to humans, will give rise to some (because aspartate can follow other metabolic pathways, it would be expected to be little) radioactive guanidinosuccinate in the urine. Thus the g. A question that needs answering is whether the enzyme catalyzing the formation of ureidohomoserine from canaline and carbamoyl phosphate is the same enzyme that catalyzes the formation of citrulline. Figure  2 demonstrates that the optimum pH for citrulline formation is 7.6, for ureidohomoserine, 7.9. These figures are too close to suggest that we are dealing with two different enzymes.
The affinity of canaline for the enzyme is substantially less than that for ornithine. This can be seen in Table 2 , where the Km with canaline as the substrate is over 10-fold that when ornithine is the substrate. Once the substrates are bound, the canaline complex has a ne stronger affinity for carbamoyl phosphate. Figure 5 shows that under the same conditions citrulline is formed 2.6 times more rapidly than ureidohomoserme.
Attempts to separate the two activities by ammonium sulfate fractionation were inconclusive. From Table 3 it is apparent that most of the activity in both cases is associated with the precipitate formed at 70% saturation with ammonium sulfate. However, the ratio of specific activity of the two activities in this fraction (2.6) was only a little more than half that noted in the initial and 60%-saturation fraction. This indicates that the 70% precipitate was more effective than the 60% or initial fraction in forming ureidohomoserine, as compared to citrulline. This could indicate that more than one enzyme is present, that an inhibitor selective for ureidohomoserine formation has been removed, or both.
Fractionation on Sephadex did not resolve the two activities. It is apparent from Figure 6 that there are at least five overlapping peaks in the ornithine carbamoyltransferase activity curve, each showing some activity. The peak with most of the ornithine carbamoyltransferase activity, at 170 ml, showed the molecular weight tobe about 120 000, as calculated from reference compounds run on the same column. The major activity peak for both canaline and ornithine are at this location. It is interesting to note that, in Escherichia coli, the molecular weight of the enzyme corresponding to our human liver preparation has been shown to be 105000 (13) .
We also studied the effect of heat, to see whether we could destroy one of the activities without the other. At 55 C the denaturation of both enzyme activities followed a similar course so that at 25 mm 61% of the ornithine carbamoyltransferase activity and 54% of the canaline carbamoyltransferase activity had been destroyed.
With both enzymes the products of the reaction, citrulline and ureidohomoserine, are strong competitive inhibitors ( Figure 7A) , and it appears that both products have a strong affinity for the active site. It would be expected that canaline and ornithine would inhibit the action of the enzymes on each other, but this is not the case, except at high concentration ( Figure 7B ). This would support the argument that the same site is not being occupied by these two substrates. This requires further study.
Our studies on the cycle shown in Figure 1 are now complete, but they bring up the question of how canaline is formed initially. No mechanism, either in plants or animals, has been demonstrated for its formation, It requires replacement of the carboxyl group of aspartate by the -CH2---O-NH2
linkage. The demonstration of this reaction would place canaline as a significant intermediate in human metabolism. Canavanine will transamidinate to ornithine to produce arginine and canaline (14) . The reaction is reversible. Thus the cycle shown in Figure 1 interlocks the urea cycle.
